MedTrace Logo

The Ailliance Post-Market Clinical Study

NCT05856370 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2026-05-12

No results posted yet for this study

Summary

The purpose of this clinical study is to collect performance and safety data for post-market Medtronic devices indicated for cranial and/or spinal indication(s).

Subjects are enrolled and followed postoperatively to 24 months. The Ailliance clinical study is intended to collect data congruous with routine clinical care practices.

Conditions

  • Spinal Deformity
  • Spinal Degenerative Disorder
  • Spinal Fusion Failure
  • Spinal Trauma
  • Spinal Tumor Case

Interventions

DEVICE

Follow-up schedule: pre-operative baseline up to 24-months post-procedure

Follow-up assessments will be required (therefore interventional) from pre-operative baseline to 24 months post index surgery

Sponsors & Collaborators

  • Medtronic Cardiac Rhythm and Heart Failure

    collaborator INDUSTRY

  • Medtronic Spinal and Biologics

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2031-05-31
Completion
2031-05-31
FDA Device
Yes

Countries

  • United States
  • France
  • Portugal
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05856370 on ClinicalTrials.gov